SAM
CVS icon

Smartleaf Asset Management’s CVS Health CVS Stock Holding History

Smartleaf Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.91M Buy
27,185
+1,164
+4% +$89.7K 0.07% 251
2025
Q4 		$2.08M Buy
26,021
+5,636
+28% +$444K 0.08% 222
2025
Q3 		$1.54M Buy
20,385
+5,326
+35% +$365K 0.1% 235
2025
Q2 		$1.03M Buy
15,059
+164
+1% +$10.8K 0.09% 245
2025
Q1 		$1M Buy
14,895
+4,170
+39% +$250K 0.1% 231
2024
Q4 		$471K Buy
10,725
+760
+8% +$42.6K 0.05% 341
2024
Q3 		$612K Sell
9,965
-1,289
-11% -$75.2K 0.07% 271
2024
Q2 		$657K Buy
11,254
+2,829
+34% +$177K 0.11% 216
2024
Q1 		$669K Buy
8,425
+1,623
+24% +$124K 0.13% 183
2023
Q4 		$525K Buy
+6,802
New +$484K 0.14% 164

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Smartleaf Asset Management's CVS Position: Q1 2026 in Review

Smartleaf Asset Management increased its CVS Health (CVS) stake by 4.5% in Q1 2026, buying an estimated $89.7K and bringing the position to 27,185 shares worth $1.91M. The position accounts for 0.07% of the portfolio, ranked #251.

Smartleaf Asset Management first reported a position in CVS in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.08M in Q4 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Smartleaf Asset Management held 27,185 shares of CVS Health worth $1.91M as of Q1 2026.
  • Smartleaf Asset Management bought 1,164 CVS Health shares in Q1 2026, an estimated $89.7K.
  • CVS Health made up 0.07% of Smartleaf Asset Management's portfolio in Q1 2026, its #251 holding.
  • Smartleaf Asset Management first reported a position in CVS Health in Q4 2023 and has held it in 10 quarters since.
  • Smartleaf Asset Management's CVS Health position peaked at $2.08M in Q4 2025.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.